Acusphere, Inc. (ACUSD.PK) today announced that it has submitted the Marketing Authorisation Application (MAA) for its lead product candidate, Imagify™ (Perflubutane Polymer Microspheres) lyophilisate ...
OVH Datacenter in France was engulfed in flames, taking down thousands of sites and businesses including popular plugins WP Rocket and Imagify. A multitude of businesses are tweeting updates to their ...
Acusphere Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for approval to market its lead product candidate, Imagify™ (Perflubutane Polymer ...
WATERTOWN, Mass., Dec 10, 2008 (BUSINESS WIRE) -- Acusphere, Inc. today announced that NASDAQ has halted trading in the Company's common stock today. The Cardio Renal Advisory Committee to the U.S.
SILVER SPRING, Md., Dec 10 (Reuters) - A U.S. Food and Drug Administration advisory panel rejected Acusphere Inc's imaging contrast agent on Wednesday, saying possible risks outweighed its potential ...
LOS ANGELES, Oct 8 (Reuters) - Acusphere Inc , whose shares fell almost 19 percent on Monday, said there has been no official statement from the U.S. Food and Drug Administration regarding its ...
Cephalon is paying $20 million in up-front financing to Acusphere for an exclusive worldwide license to AI-525, a preclinical-stage injectable form of the anti-inflammatory drug celecoxib, which is ...
Acusphere Announces Submission of Marketing Authorisation Application for Imagify™ in Europe and Sta
LEXINGTON, Mass.--(BUSINESS WIRE)-- Acusphere, Inc. (ACUSD.PK) today announced that it has submitted the Marketing Authorisation Application (MAA) for its lead product candidate, Imagify™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results